Your browser doesn't support javascript.
loading
Targeted Molecular Therapeutics for Parkinson's Disease: A Role for Antisense Oligonucleotides?
Li, Dunhui; Mastaglia, Frank L; Yau, Wai Yan; Chen, Shengdi; Wilton, Steve D; Akkari, Patrick A.
Afiliación
  • Li D; Perron Institute for Neurological and Translational Science, The University of Western Australia, Nedlands, Australia.
  • Mastaglia FL; Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Murdoch, Australia.
  • Yau WY; College of Nursing and Health, Zhengzhou University, Zhengzhou, China.
  • Chen S; Perron Institute for Neurological and Translational Science, The University of Western Australia, Nedlands, Australia.
  • Wilton SD; Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Murdoch, Australia.
  • Akkari PA; Perron Institute for Neurological and Translational Science, The University of Western Australia, Nedlands, Australia.
Mov Disord ; 37(11): 2184-2190, 2022 11.
Article en En | MEDLINE | ID: mdl-36036206
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Oligonucleótidos Antisentido Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Oligonucleótidos Antisentido Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article